Journey Medical Corp. (DERM), a commercial-stage pharmaceutical company headquartered in Scottsdale, Arizona, is drawing attention with steady gains in recent trading. The company specializes in dermatological treatments, offering a portfolio that includes Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm, Targadox, Emrosi, and Luxamend. Its focus on both established therapies and new product launches positions it as an active player in the dermatology market.
Clinical Validation and Payer Expansion for Emrosi
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.